[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@vjoncology Avatar](https://lunarcrush.com/gi/w:26/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg.png) @vjoncology VJOncology

VJOncology posts on YouTube about nct, university of, germany, italy the most. They currently have XXXXXX followers and 1932 posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:interactions.svg)

- X Week XXXXX +1,431%
- X Month XXXXX +14%
- X Months XXXXXX +36%
- X Year XXXXXX +110%

### Mentions: XX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:posts_active.svg)

- X Week XX +338%
- X Month XXX -XX%
- X Months XXX +53%
- X Year XXXXX +347%

### Followers: XXXXXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:followers.svg)

- X Week XXXXXX +0.65%
- X Month XXXXXX +1.30%
- X Months XXXXXX +7.60%
- X Year XXXXXX +20%

### CreatorRank: XXXXXXXXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/influence)
---

**Social category influence**
[countries](/list/countries)  [travel destinations](/list/travel-destinations)  [luxury brands](/list/luxury-brands)  [currencies](/list/currencies) 

**Social topic influence**
[nct](/topic/nct) #702, [university of](/topic/university-of) #1297, [germany](/topic/germany), [italy](/topic/italy), [london](/topic/london), [milan](/topic/milan) #1428, [canada](/topic/canada), [japan](/topic/japan), [sydney](/topic/sydney), [australia](/topic/australia)
### Top Social Posts [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts)
---
Top posts by engagements in the last XX hours

"INTEGRATE IIb: regorafenib plus nivolumab in advanced gastric cancer"  
[YouTube Link](https://youtube.com/watch?v=-kEGNyCIovg) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T07:28Z 15.5K followers, XX engagements


"RENALUT: 177Lu-PSMA-617 in metastatic pre-treated ccRCC"  
[YouTube Link](https://youtube.com/watch?v=-u38KMmpmzo) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T14:14Z 15.6K followers, XX engagements


"Melanoma at ESMO 2025: SWOG S1801 NADINA and more"  
[YouTube Link](https://youtube.com/watch?v=76Gn2EgcAUE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T09:32Z 15.5K followers, XX engagements


"Capturing clonal evolution of ccRCC through histology"  
[YouTube Link](https://youtube.com/watch?v=HweaK5uF1wQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:43Z 15.6K followers, XX engagements


"GDFather-NEO: neoadjuvant nivolumab with or without visugromab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=ZIHWrJymYSE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T07:34Z 15.5K followers, XX engagements


"ADRISK: pembrolizumab plus adjuvant chemoradiation in HNSCC"  
[YouTube Link](https://youtube.com/watch?v=prN1pAD5WMk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T13:28Z 15.5K followers, XX engagements


"ASCO 2025 highlights in breast cancer: ASCENT-04 SERENA-6 and more"  
[YouTube Link](https://youtube.com/watch?v=wDk_Bmjg0fo) [@vjoncology](/creator/youtube/vjoncology) 2025-07-28T11:28Z 15.5K followers, XXX engagements


"Ask the Expert: Stephanie Graff answers your breast cancer questions at ESMO 2025"  
[YouTube Link](https://youtube.com/watch?v=3QhB_xsYG7U) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T06:26Z 15.6K followers, XX engagements


"FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors"  
[YouTube Link](https://youtube.com/watch?v=8KRENmnchO8) [@VJOncology](/creator/youtube/VJOncology) 2025-10-22T09:59Z 15.6K followers, X engagements


"Insights into novel treatment strategies for early-stage ALK-positive NSCLC"  
[YouTube Link](https://youtube.com/watch?v=BETr6TBdZME) [@vjoncology](/creator/youtube/vjoncology) 2025-09-12T13:47Z 15.6K followers, XX engagements


"Immunotherapy for recurrent respiratory papillomatosis (RRP) using PRGN-2012"  
[YouTube Link](https://youtube.com/watch?v=H8wqkCeyGg8) [@vjoncology](/creator/youtube/vjoncology) 2024-07-09T16:54Z 15.6K followers, XXX engagements


"Combination ADC approaches in breast cancer"  
[YouTube Link](https://youtube.com/watch?v=Owlki7yIzGQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T07:54Z 15.6K followers, XX engagements


"The importance of understanding clonal evolution through histological analysis in oncology"  
[YouTube Link](https://youtube.com/watch?v=RR_T-7vgodM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:51Z 15.6K followers, XX engagements


"De-escalating bone modifying agents"  
[YouTube Link](https://youtube.com/watch?v=2uWhIpC5Sro) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T16:16Z 15.6K followers, XX engagements


"5-year follow-up of CheckMate 648: NIVO plus chemo or IPI vs chemo as 1L treatment for advanced ESCC"  
[YouTube Link](https://youtube.com/watch?v=4av3F4uNYPg) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T13:36Z 15.6K followers, XX engagements


"T-DXd vs T-DM1 in high-risk HER2+ breast cancer: DESTINY-Breast05 interim data"  
[YouTube Link](https://youtube.com/watch?v=9JpJ5LRoFG8) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T14:10Z 15.6K followers, XX engagements


"KANDLELIT-001: MK-1084 monotherapy in KRAS G12C- mutated advanced solid tumors"  
[YouTube Link](https://youtube.com/watch?v=9bbCmKFDpR0) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T16:04Z 15.6K followers, XX engagements


"NIAGARA: HRQoL outcomes of perioperative durvalumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=9nD9kGK2Pgk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:50Z 15.6K followers, X engagements


"Advancements in developing inhibitors for non-G12C KRAS mutations"  
[YouTube Link](https://youtube.com/watch?v=AD5d0qO6ilI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T16:05Z 15.6K followers, XX engagements


"Dose-escalation and expansion study of 225Ac-J591 in mCRPC"  
[YouTube Link](https://youtube.com/watch?v=C4NlZ5lVHxw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T13:24Z 15.6K followers, XX engagements


"Patient-reported outcomes of mevrometostat and enzalutamide in mCRPC"  
[YouTube Link](https://youtube.com/watch?v=CGkmSo4dWi8) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T12:16Z 15.6K followers, XX engagements


"The potential of spatial biology & clonal evolution mapping to transform precision cancer treatment"  
[YouTube Link](https://youtube.com/watch?v=EIQxxTHivnQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:52Z 15.6K followers, XX engagements


"CheckMate 274: 5-year results of adjuvant nivolumab in MIUC"  
[YouTube Link](https://youtube.com/watch?v=F9WwOAcZjBI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T06:38Z 15.6K followers, XX engagements


"Primary OS analysis of Phase III STELLAR-303: zanza + atezo vs rego in previously treated mCRC"  
[YouTube Link](https://youtube.com/watch?v=Gx3BDabmwvc) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T16:52Z 15.6K followers, XX engagements


"The potential role of T-Dxd in the first-line setting for HER2+ unresectable/metastatic GC/GEJA"  
[YouTube Link](https://youtube.com/watch?v=GxCnZmnUkic) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:17Z 15.6K followers, XX engagements


"Ask the Expert: Kevin Kalinsky answers your breast cancer questions at ESMO 2025"  
[YouTube Link](https://youtube.com/watch?v=K-faGzBnoDM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:57Z 15.6K followers, XX engagements


"IMvigor011: ctDNA-guided adjuvant atezolizumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=Mu4eFZAPxkw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:58Z 15.6K followers, XX engagements


"ADCs in earlier-line metastatic breast cancer: insights from DESTINY-Breast09 & ASCENT-03"  
[YouTube Link](https://youtube.com/watch?v=NK22EaCr9oE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T14:18Z 15.6K followers, XX engagements


"Management of interstitial lung disease in the DESTINY-Breast05 trial"  
[YouTube Link](https://youtube.com/watch?v=P2iPlS1lFFw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:55Z 15.6K followers, XX engagements


"PSMAddition: 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC"  
[YouTube Link](https://youtube.com/watch?v=PKEJ1xtMCBQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T13:09Z 15.6K followers, XX engagements


"DESTINY-Breast05: T-DXd vs T-DM1 in high-risk HER2+ early breast cancer"  
[YouTube Link](https://youtube.com/watch?v=R3C9KfnZ1EE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:53Z 15.6K followers, XX engagements


"Remaining questions surrounding the use of T-DXd in the curative-intent setting"  
[YouTube Link](https://youtube.com/watch?v=RZSljslmuPk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T14:11Z 15.6K followers, XX engagements


"CheckMate 8HW: nivolumab & ipilimumab in MSI-H/dMMR metastatic CRC"  
[YouTube Link](https://youtube.com/watch?v=UzupwedDjuI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T14:36Z 15.6K followers, X engagements


"DISCUS: comparing X vs X chemotherapy cycles before avelumab in aUC"  
[YouTube Link](https://youtube.com/watch?v=_z8Y2ysRCwQ) [@VJOncology](/creator/youtube/VJOncology) 2025-10-22T10:09Z 15.6K followers, XX engagements


"Final results of OBP101JP: oncolytic virotherapy + suratadenoturev + RT for esophageal cancer"  
[YouTube Link](https://youtube.com/watch?v=cj1qZ5IPko0) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T15:23Z 15.6K followers, XXX engagements


"SWOG S1801: 3-year outcomes of neoadjuvant-adjuvant pembrolizumab"  
[YouTube Link](https://youtube.com/watch?v=exJeDv0uzTk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:07Z 15.6K followers, XX engagements


"Identifying biomarkers in first-line mccRCC therapy in the COSMIC XXX trial"  
[YouTube Link](https://youtube.com/watch?v=faH-hlbt1-w) [@VJOncology](/creator/youtube/VJOncology) 2025-10-18T08:51Z 15.6K followers, XX engagements


"The evolving landscape of gastroesophageal cancer treatment"  
[YouTube Link](https://youtube.com/watch?v=kaMGFM867aE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:19Z 15.6K followers, XX engagements


"REaCT-Hold BMA: managing bone-modifying agents after 2+ years in metastatic breast cancer/CRPC"  
[YouTube Link](https://youtube.com/watch?v=mgIiL9BonFw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T16:10Z 15.6K followers, XX engagements


"EMBARK: final OS results of enzalutamide in hrBCR prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=rVgkdIr5FBw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T11:49Z 15.6K followers, XX engagements


"Evolving standards in first-line metastatic urothelial cancer"  
[YouTube Link](https://youtube.com/watch?v=rrYg0LsdE0E) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:17Z 15.6K followers, X engagements


"RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in HER2+ la/mUC"  
[YouTube Link](https://youtube.com/watch?v=rucT4oIVunU) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:48Z 15.6K followers, X engagements


"EMERALD: eribulin plus dual HER2 blockade in first-line HER2+ breast cancer"  
[YouTube Link](https://youtube.com/watch?v=rzIV4t1ffcI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T13:44Z 15.6K followers, XX engagements


"MonarchE: Ki-67 dynamics and prognostic value in HR+/HER2- breast cancer"  
[YouTube Link](https://youtube.com/watch?v=sZqJZdyV1bE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T13:35Z 15.6K followers, XX engagements


"OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic ccRCC"  
[YouTube Link](https://youtube.com/watch?v=sbkc7DrEPEQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:28Z 15.6K followers, XX engagements


"MRD assessment & ctDNA monitoring to guide treatment post-surgery in GI cancer"  
[YouTube Link](https://youtube.com/watch?v=v72AlMgJumg) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:21Z 15.6K followers, XX engagements


"EMBARK: metastasis-free survival by prior treatment in hrBCR prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=vorypB1evwQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T13:21Z 15.6K followers, XX engagements


"Optimizing ADCs in mBC: boosting efficacy & managing toxicity in earlier treatment lines"  
[YouTube Link](https://youtube.com/watch?v=xBCIvSgRR5U) [@vjoncology](/creator/youtube/vjoncology) 2025-10-21T14:20Z 15.6K followers, XX engagements


"SKYSCRAPER-07: atezolizumab with or without tiragolumab in patients with unresectable ESCC"  
[YouTube Link](https://youtube.com/watch?v=zKXCj2-m7qI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T13:32Z 15.6K followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@vjoncology VJOncology

VJOncology posts on YouTube about nct, university of, germany, italy the most. They currently have XXXXXX followers and 1932 posts still getting attention that total XXX engagements in the last XX hours.